Solution- and solid-phase synthesis of the polybasic lipid-modified C termini of Rho A and K-Ras 4B

ChemBioChem

Volumn 3, Issue 9, 2002, Pages 901-904

  Ludolph, Björn ^a   Eisele, Frank ^c   Waldmann, Herbert ^a,b  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

^c CarboGen Laboratories (Neuland) AG   (Switzerland)

Author keywords

Lipopetides; Lipoproteins; Ras proteins; Rho proteins; Solid phase synthesis

Indexed keywords

AMINOCAPROIC ACID; BIOTIN; LIPID; PROTEIN RHO A; RAS PROTEIN; RHO KINASE; UNCLASSIFIED DRUG; URETHAN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL MODIFICATION; CHEMICAL REACTION; LIPOGENESIS; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN SYNTHESIS; REACTION ANALYSIS; SOLID;

DITERPENES; FARNESOL; HUMANS; LIPIDS; PEPTIDES; PROTO-ONCOGENE PROTEINS; RHOA GTP-BINDING PROTEIN;

EID: 12244281112     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/1439-7633(20020902)3:9<901::AID-CBIC901>3.0.CO;2-U     Document Type: Article

References (26)

1. D. Kadereit, J. Kuhlmann, H. Waldmann, ChemBioChem 2000, 1, 144-169; M. Völkert, M. Wagner, C. Peters, H. Waldmann, Biol. Chem. 2001, 382, 1133-1145.
2. D. Kadereit, J. Kuhlmann, H. Waldmann, ChemBioChem 2000, 1, 144-169; M. Völkert, M. Wagner, C. Peters, H. Waldmann, Biol. Chem. 2001, 382, 1133-1145.
3. K. Kuhn, D. J. Owen, B. Bader, A. Wittinghofer, J. Kuhlmann, H. Waldmann, J. Am. Chem. Soc. 2001, 123, 1023-1035; E. Nägele, M. Scheelhaas, N. Kuder, H. Waldmann, J. Am. Chem. Soc. 1998, 120, 6889-6902.
4. K. Kuhn, D. J. Owen, B. Bader, A. Wittinghofer, J. Kuhlmann, H. Waldmann, J. Am. Chem. Soc. 2001, 123, 1023-1035; E. Nägele, M. Scheelhaas, N. Kuder, H. Waldmann, J. Am. Chem. Soc. 1998, 120, 6889-6902.
5. D. Kadereit, H. Waldmann, ChemBioChem 2000, 3, 200-203.
6. For solid-phase approaches, see: a) P. Mayer-Fligge, J. Volz, U. Krüger, E. Sturm, W. Gernandt, K. P. Schäfer, M. Przybylski, J. Pept. Sci. 1998, 4, 355-363;
7. b) B. Denis, E. Trifilieff, J. Pept. Sci. 2000, 6, 372-377;
8. c) S. P. Creaser, B. R. Peterson, J. Am. Chem. Soc. 2002, 124, 2444-2445;
9. d) B. Ludolph, F. Eisele, H. Waldmann, J. Am. Chem. Soc. 2002, 124, 5954-5955;
10. e) E. K. Dolence, J. M. Dolence, C. D. Poulter, Bioconjugate Chem. 2001, 12, 35-43.
11. a) A. Welmann, M. M. Burger, J. Hagmann, Oncogene 2000, 19, 4582-4591;
12. b) M. O. Roy, R. Leventis, J. R. Silvius, Biochemistry 2000, 39, 8298-8307;
13. c) A. Apolloni, I. A. Prior, M. Lindsay, R. G. Parton, J. F. Hancock, Mol. Cell Biol. 2000, 20, 2475-2487;
14. d) E. Choy, V. K. Chiu, J. Silletti, M. Feoktistov, T. Morimoto, D. Michaelson, I. E. Ivanov, M. R. Philips, Cell 1999, 98, 69-80.
15. S. M. Sebti, A.D. Hamilton, Oncogene 2000, 19, 6584-6593; S.M. Sebti, A. D. Hamilton, Expert Opin. Invest. Drugs 2000, 9, 2767-2782.
16. S. M. Sebti, A.D. Hamilton, Oncogene 2000, 19, 6584-6593; S.M. Sebti, A. D. Hamilton, Expert Opin. Invest. Drugs 2000, 9, 2767-2782.
17. F. Ghomashchi, X. Zhang, L. Liu, M. H. Gelb, Biochemistry 1995, 34, 11910-11918.
18. M. Gelb, personal communication.
19. R. Leventis, J. R. Silvius, Biochemistry 1998, 37, 7640-7648.
20. T. Schmittberger, H. Waldmann, Bioorg. Med. Chem. 1999, 7, 749-762.
21. E. J. Corey, C. U. Kim, M. Takeda, Tetrahedron Lett. 1972, 4339-4342.
22. S. Rio, J.-M. Beau, J.-C. Jacquinet, Carbohydr. Res. 1991, 219, 71-90.
23. Senn Chemicals.
24. M. Dessolin, M.-G. Guillerez, N. Thieriet, F. Guibé, A. Loffet, Tetrahedron Lett. 1995, 5741-5744.
25. Novabiochem.
26. D. Kadereit, P. Deck, I. Heinemann, H. Waldmann, Chem. Eur. J. 2001, 7, 1184-1193.